Stock Scorecard
Stock Summary for Embecta Corp (EMBC) - $5.19 as of 9/18/2026 7:27:13 PM EST
Total Score
12 out of 30
Safety Score
22 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for EMBC
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for EMBC
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for EMBC
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for EMBC
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for EMBC (22 out of 100)
| Stock Price Rating (Max of 10) | 4 |
| Historical Stock Price Rating (Max of 10) | 7 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 1 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 0 |
| Analyst Strong Buy Ratings (Max of 5) | 0 |
| Dividend Yield Percentage (Max of 10) | 8 |
| Operating Margin (Max of 10) | 5 |
| Trading Volume (Max of 10) | 6 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | -10 |
Latest News for for EMBC
Financial Details for EMBC
Company Overview |
|
|---|---|
| Ticker | EMBC |
| Company Name | Embecta Corp |
| Country | N/A |
| Description | Embecta Corp (EMBC) is a leading medical technology company specializing in innovative insulin delivery systems aimed at enhancing diabetes management. Born from a spin-off of Becton, Dickinson and Company, Embecta provides a comprehensive portfolio of advanced products, including cutting-edge insulin pens and syringes tailored to improve patient outcomes. With a robust focus on operational excellence and customer satisfaction, Embecta is well-positioned to capitalize on growth opportunities in the rapidly expanding diabetes care market, strengthening its leadership in this vital sector. |
| Sector Name | HEALTHCARE |
| Industry Name | MEDICAL INSTRUMENTS & SUPPLIES |
| Most Recent Quarter | 6/30/2026 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 5.19 |
| Price 4 Years Ago | 22.10 |
| Last Day Price Updated | 9/18/2026 7:27:13 PM EST |
| Last Day Volume | 570,883 |
| Average Daily Volume | 1,618,705 |
| 52-Week High | 15.05 |
| 52-Week Low | 2.76 |
| Last Price to 52 Week Low | 88.04% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 57.74 |
| Sector PE | 39.10 |
| 5-Year Average PE | 3.76 |
| Free Cash Flow Ratio | 1.37 |
| Industry Free Cash Flow Ratio | 38.07 |
| Sector Free Cash Flow Ratio | 34.28 |
| Current Ratio Most Recent Quarter | 1.68 |
| Total Cash Per Share | 3.79 |
| Book Value Per Share Most Recent Quarter | -10.81 |
| Price to Book Ratio | 2.61 |
| Industry Price to Book Ratio | 3.80 |
| Sector Price to Book Ratio | 28.55 |
| Price to Sales Ratio Twelve Trailing Months | 0.29 |
| Industry Price to Sales Ratio Twelve Trailing Months | 5.99 |
| Sector Price to Sales Ratio Twelve Trailing Months | 23.22 |
| Analyst Buy Ratings | 0 |
| Analyst Strong Buy Ratings | 0 |
Share Statistics |
|
| Total Shares Outstanding | 56,660,000 |
| Market Capitalization | 294,065,400 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | 8/27/2026 |
| Previous Dividend Amount | 0.0100 |
| Current Dividend Amount | 0.0100 |
| Total Years Dividend Increasing | 0 |
| Trailing Annual Dividend Rate | 0.32 |
| Trailing Annual Dividend Yield | 6.24% |
| Forward Annual Dividend Rate | 0.04 |
| Forward Annual Dividend Yield | 0.78% |
| 5-Year Dividend Payments Count | 17 |
| 3-Year Average Dividend Yield | 5.15% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | -93.33% |
| 3-Year Dividend Growth Rate Percentage | -74.18% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | 21.77% |
Income Statement |
|
| Quarterly Earnings Growth YOY | -53.70% |
| Annual Earnings Growth | 21.84% |
| Reported EPS 12 Trailing Months | 1.47 |
| Reported EPS Past Year | 1.54 |
| Reported EPS Prior Year | 2.97 |
| Net Income Twelve Trailing Months | 87,500,000 |
| Net Income Past Year | 95,400,000 |
| Net Income Prior Year | 78,300,000 |
| Quarterly Revenue Growth YOY | -8.10% |
| 5-Year Revenue Growth | -0.09% |
| Operating Margin Twelve Trailing Months | 23.70% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 214,700,000 |
| Total Cash Past Year | 225,500,000 |
| Total Cash Prior Year | 267,500,000 |
| Net Cash Position Most Recent Quarter | -1,101,000,000 |
| Net Cash Position Past Year | -1,163,200,000 |
| Long Term Debt Past Year | 1,388,700,000 |
| Long Term Debt Prior Year | 1,565,300,000 |
| Total Debt Most Recent Quarter | 1,315,700,000 |
| Equity to Debt Ratio Past Year | -0.88 |
| Equity to Debt Ratio Most Recent Quarter | -0.87 |
| Total Stockholder Equity Past Year | -651,200,000 |
| Total Stockholder Equity Prior Year | -738,300,000 |
| Total Stockholder Equity Most Recent Quarter | -612,700,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 164,600,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 2.91 |
| Free Cash Flow Past Year | 182,400,000 |
| Free Cash Flow Prior Year | 19,900,000 |
Options |
|
| Put/Call Ratio | 2.22 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.00 |
| MACD Signal | 0.00 |
| 20-Day Bollinger Lower Band | 0.00 |
| 20-Day Bollinger Middle Band | 0.00 |
| 20-Day Bollinger Upper Band | 0.00 |
| Beta | 0.85 |
| RSI | 0.00 |
| 50-Day SMA | 0.00 |
| 150-Day SMA | 11.69 |
| 200-Day SMA | 14.28 |
System |
|
| Modified | 9/17/2026 10:17:31 PM EST |